Ameriprise Financial Inc Eiger Bio Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.21 - $0.43 $228,255 - $467,380	-1,086,932 Reduced 12.65%	7,505,539 $1.65 Million
Q2 2023 Aug 14, 2023	BUY	$0.55 - $1.26 $310,716 - $711,823	564,939 Added 7.04%	8,592,471 $6.01 Million
Q1 2023 May 15, 2023	BUY	$0.89 - $2.52 $2.3 Million - $6.51 Million	2,582,776 Added 47.44%	8,027,532 $7.22 Million
Q4 2022 Feb 14, 2023	SELL	$1.02 - $7.48 $2.68 Million - $19.7 Million	-2,629,541 Reduced 32.57%	5,444,756 $6.42 Million
Q3 2022 Nov 14, 2022	BUY	$6.04 - $9.66 $2.41 Million - $3.85 Million	398,720 Added 5.19%	8,074,297 $60.8 Million
Q2 2022 Aug 15, 2022	BUY	$4.99 - $8.96 $900,764 - $1.62 Million	180,514 Added 2.41%	7,675,577 $48.4 Million
Q1 2022 May 16, 2022	BUY	$3.84 - $9.74 $1.73 Million - $4.39 Million	450,329 Added 6.39%	7,495,063 $62.2 Million
Q4 2021 Feb 14, 2022	BUY	$5.12 - $8.19 $5.81 Million - $9.3 Million	1,135,073 Added 19.21%	7,044,734 $36.6 Million
Q3 2021 Nov 15, 2021	BUY	$6.68 - $9.1 $2.64 Million - $3.59 Million	394,630 Added 7.16%	5,909,661 $39.5 Million
Q2 2021 Aug 16, 2021	BUY	$7.82 - $9.23 $8.33 Million - $9.83 Million	1,064,790 Added 23.93%	5,515,031 $47 Million
Q1 2021 May 17, 2021	BUY	$8.44 - $12.66 $4.46 Million - $6.69 Million	528,406 Added 13.47%	4,450,241 $39.4 Million
Q4 2020 Feb 12, 2021	BUY	$7.98 - $12.29 $20.2 Million - $31.1 Million	2,529,780 Added 181.73%	3,921,835 $48.2 Million
Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $11.1 Million - $17.3 Million	1,392,055 New	1,392,055 $11.3 Million

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.